There’s no single medical test to diagnose Lewy body dementia. Doctors generally use a combination of medical history and physical examination, plus neuropsychological testing to assess thinking, ...

Sue's Story: A Journey with Lewy Body Dementia has been presented in Continuing Medical Education programs offered by Kaiser Permanente and other health systems; in nursing programs offered by ...

28, 2025 /PRNewswire/ -- Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's Story: A Journey with Lewy Body Dementia ...

Researchers at Lund University in Sweden have made a major breakthrough in diagnosing Lewy body disease, a leading cause of dementia. Until now, the only way to confirm the disease was through a ...

Lewy Body Dementia is a brain disease that mainly targets people above 50. It’s an incurable disease that doesn’t allow the patient to lead an ordinary life; they won’t be able to do their everyday ...

CervoMed Inc. announced that it will present topline results from its Phase 2b RewinD-LB study at the 8th International Lewy Body Dementia Conference in Amsterdam on January 31, 2025. The study ...

A new study from Karolinska Institutet and Mayo Clinic has revealed important insights into brain degeneration in dementia with Lewy bodies ... seen on FDG-PET scans go in hand with worsening ...

Anosmia appears to be common in dementia with Lewy bodies but not in pure Alzheimer’s disease. Objective: To determine whether anosmia improves discrimination between the Lewy body variant (LBV) of ...

However, medical conditions can sometimes affect posture. According to the Alzheimer’s Society, those with Lewy body dementia experience movement difficulties, such as changes to their posture ...

A new study from Karolinska Institutet and Mayo Clinic has revealed important insights into brain degeneration in dementia with ... Metabolic Change Along the Lewy Body Continuum, JAMA Neurology ...

29, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that topline results from the ...